How I treat age-related morbidities in elderly persons with hemophilia
P.M. Mannucci(Ospedale Maggiore), Evelien P. Mauser‐Bunschoten(University Medical Center Utrecht), Elena Santagostino(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Roger E. G. Schutgens(University Medical Center Utrecht)
Cited by 185
Related Papers
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|491
Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B
|Blood|2017|300
Clinical severity of haemophilia A: does the classification of the 1950s still stand?
|Haemophilia|2011|244
COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
|The Lancet Haematology|2021|237